Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Neon Therapeutics Inc (NTGN_old)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Neon Therapeutics's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
Neon Therapeutics historical data, for real-time data please try another search
3.070 +0.000    +0.00%
05/05 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 2.915 - 3.090
Neon Therapeutics 3.070 +0.000 +0.00%

Neon Therapeutics Inc Company Profile

 
Get an in-depth profile of Neon Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
Industry
Sector
Employees

71

Equity Type

ORD

BioNTech US Inc. operates as a clinical-stage immuno-oncology company that develops neoantigen-targeted therapies for cancer. It offers NEO-PV-01, a neoantigen vaccine for the treatment of metastatic non-small cell lung cancer; NEO-PTC-01, a neoantigen T cell therapy for the treatment of solid tumors; NEO-SV-01, a neoantigen vaccine for the treatment of hormone receptor-positive breast cancer; and NEO-STC-01, a neoantigen adoptive T cell therapy for the treatment of cancers driven or mediated by RAS mutations. BioNTech US Inc. was formerly known as Neon Therapeutics, Inc. and changed its name to BioNTech US Inc. in May 2020. The company was incorporated in 2013 and is based in Cambridge, Massachusetts, with additional locations across the globe. As of May 7, 2020, BioNTech US Inc. operates as a subsidiary of BioNTech SE.

Contact Information

Address 40 Erie Street Suite 110
Cambridge, 02139
United States
Phone 617 337 4701
Fax -
Web www.biontech.com/int/en/home/about/biontech-us-website.html
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

NTGN_old Comments

Write your thoughts about Neon Therapeutics Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Joshua Morales
Joshua Morales Sep 11, 2019 10:22AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
position @ 3.12 let's see how high
Reply
0 0
Report
Bawor Bruno
Bawor Bruno Sep 11, 2019 10:22AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Joshua, today, 17/3/20 price at 1.83, if you have not hit an automatic stop-loss, your stock already loss about 40%
Reply
0 0
Report
Fancy Osazuwa
Fancy Osazuwa Jul 02, 2018 2:48AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Just found this stock !!! Let’s see how it goes! No balance sheet so earnings will be a big deal ha
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email